HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yan Chen Selected Research

xanthosine

1/2020Alterations of Proximal Tubular Secretion in Autosomal Dominant Polycystic Kidney Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yan Chen Research Topics

Disease

548Neoplasms (Cancer)
10/2022 - 08/2003
143Inflammation (Inflammations)
08/2022 - 08/2003
110Infections
12/2022 - 04/2003
95Neoplasm Metastasis (Metastasis)
09/2022 - 05/2003
80Breast Neoplasms (Breast Cancer)
05/2022 - 05/2007
67Fibrosis (Cirrhosis)
04/2022 - 05/2007
65Hepatocellular Carcinoma (Hepatoma)
12/2022 - 04/2003
63Chronic Obstructive Pulmonary Disease (COPD)
08/2022 - 08/2004
62Carcinogenesis
04/2022 - 04/2003
54Hypoxia (Hypoxemia)
07/2022 - 11/2003
47Leukemia
05/2022 - 04/2002
47Lung Neoplasms (Lung Cancer)
01/2022 - 08/2003
44Carcinoma (Carcinomatosis)
10/2022 - 08/2003
42Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 09/2007
41Body Weight (Weight, Body)
12/2022 - 01/2002
38Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 02/2004
36Insulin Resistance
04/2022 - 12/2002
34Obesity
05/2022 - 06/2008
32Stomach Neoplasms (Stomach Cancer)
02/2022 - 09/2012
31Asthma (Bronchial Asthma)
10/2022 - 04/2010
31Stroke (Strokes)
09/2022 - 12/2006
30COVID-19
12/2022 - 01/2020
30Type 2 Diabetes Mellitus (MODY)
03/2022 - 09/2010
27Liver Neoplasms (Liver Cancer)
02/2022 - 10/2011
26Emphysema
08/2022 - 08/2005
26Hypertension (High Blood Pressure)
01/2022 - 09/2009
23Cardiovascular Diseases (Cardiovascular Disease)
02/2022 - 01/2012
22Atherosclerosis
10/2022 - 01/2007
21Adenocarcinoma of Lung
04/2022 - 09/2008
21Rheumatoid Arthritis
02/2022 - 04/2014
21Pain (Aches)
01/2022 - 01/2007
21Necrosis
12/2021 - 12/2005
21Parkinson Disease (Parkinson's Disease)
07/2021 - 12/2004
20Wounds and Injuries (Trauma)
09/2022 - 01/2006
20Ischemia
08/2022 - 01/2005
20Hemorrhage
04/2022 - 11/2005
19Ischemic Stroke
08/2022 - 01/2014
19Osteoporosis
01/2022 - 12/2009
18Adenocarcinoma
01/2022 - 08/2003
18Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2021 - 01/2002
18Nasopharyngeal Carcinoma
01/2021 - 05/2002
17Starvation
06/2022 - 05/2002
17Diabetes Mellitus
11/2021 - 08/2004
17Multiple Myeloma
04/2021 - 10/2009
16Heart Failure
01/2021 - 01/2008

Drug/Important Bio-Agent (IBA)

235Proteins (Proteins, Gene)FDA Link
07/2022 - 01/2002
108Pharmaceutical PreparationsIBA
05/2022 - 05/2005
101Biomarkers (Surrogate Marker)IBA
08/2022 - 10/2004
79Messenger RNA (mRNA)IBA
04/2022 - 08/2003
69MicroRNAs (MicroRNA)IBA
08/2022 - 07/2008
67Biological ProductsIBA
02/2022 - 11/2005
63CytokinesIBA
10/2022 - 08/2003
52Glucose (Dextrose)FDA LinkGeneric
12/2022 - 07/2007
47DNA (Deoxyribonucleic Acid)IBA
11/2021 - 02/2004
43LipidsIBA
10/2022 - 07/2008
33SmokeIBA
08/2022 - 04/2009
33EnzymesIBA
04/2022 - 04/2002
33Small Interfering RNA (siRNA)IBA
04/2022 - 04/2007
32Therapeutic UsesIBA
09/2022 - 05/2007
32Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 01/2005
30AntigensIBA
11/2022 - 06/2006
30RNA (Ribonucleic Acid)IBA
10/2022 - 06/2006
30Long Noncoding RNAIBA
08/2022 - 05/2016
28VaccinesIBA
12/2022 - 07/2004
28Peptides (Polypeptides)IBA
03/2022 - 08/2003
24AntioxidantsIBA
08/2022 - 04/2003
24Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2022 - 06/2003
24Cisplatin (Platino)FDA LinkGeneric
02/2022 - 09/2002
24Blood Glucose (Blood Sugar)IBA
11/2021 - 12/2010
22Insulin (Novolin)FDA Link
12/2022 - 12/2002
22Histones (Histone)IBA
04/2022 - 09/2005
22CurcuminIBA
01/2022 - 01/2002
21Polysaccharides (Glycans)IBA
07/2022 - 11/2007
21Triglycerides (Triacylglycerol)IBA
01/2022 - 03/2005
20LigandsIBA
05/2022 - 06/2003
20LipopolysaccharidesIBA
02/2022 - 04/2008
20Indicators and Reagents (Reagents)IBA
12/2021 - 04/2005
20Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 06/2008
19AntibodiesIBA
07/2022 - 03/2005
19Interleukin-6 (Interleukin 6)IBA
02/2022 - 11/2003
19ErbB Receptors (EGF Receptor)IBA
01/2022 - 04/2010
18Phosphotransferases (Kinase)IBA
04/2022 - 12/2007
17Immunoglobulin E (IgE)IBA
11/2022 - 04/2010
17Liposomes (Liposome)IBA
07/2022 - 06/2005
17Transcription Factors (Transcription Factor)IBA
06/2022 - 07/2011
17GoldIBA
05/2022 - 03/2010
17CollagenIBA
04/2022 - 04/2004
17CreatinineIBA
01/2022 - 07/2011
17AlbuminsIBA
01/2022 - 06/2010
16AcidsIBA
06/2022 - 01/2010
16CateninsIBA
05/2022 - 04/2011
15Doxorubicin (Adriamycin)FDA LinkGeneric
07/2022 - 01/2002

Therapy/Procedure

286Therapeutics
12/2022 - 06/2004
86Drug Therapy (Chemotherapy)
07/2022 - 09/2002
33Radiotherapy
01/2022 - 07/2009
26Chinese Traditional Medicine (Traditional Chinese Medicine)
05/2022 - 01/2007
24Immunotherapy
10/2022 - 08/2002
20Transplantation
02/2022 - 08/2010
18Aftercare (After-Treatment)
12/2021 - 01/2005
17Length of Stay
09/2022 - 11/2008